Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease-Reference-Cited by-同舟云学术

Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease

Published:2023-10 Issue:11 Volume:21 Page:2918-2927.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Constantine-Cooke Nathan^ORCID,Monterrubio-Gómez Karla,Plevris Nikolas,Derikx Lauranne A.A.P.,Gros Beatriz,Jones Gareth-Rhys,Marioni Riccardo E.,Lees Charlie W.,Vallejos Catalina A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology;Jones;Gut,2019

2. Incidence and prevalence of inflammatory bowel disease in Devon, UK;Hamilton;Frontline Gastroenterol,2021

3. Clinical course in Crohn’s disease: results of a five-year population-based follow-up study (the IBSEN study);Henriksen;Scand J Gastroenterol,2007

4. A practical guide for faecal calprotectin measurement: myths and realities;D’Amico;J Crohns Colitis,2020

5. Association between level of fecal calprotectin and progression of Crohn’s disease;Kennedy;Clin Gastroenterol Hepatol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in inflammatory bowel disease: a practical guide;Therapeutic Advances in Gastroenterology;2024-01

2. Fecal Calprotectin Profiles in Crohn's Disease: A Longitudinal Data Analysis;Clinical Gastroenterology and Hepatology;2023-11

3. Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-05-11